National Institutes of Health principal deputy director Lawrence Tabak finally admitted to Congress that US taxpayers funded gain-of-function research at the Wuhan Institute of Virology in China before the COVID-19 pandemic.
StockNews.com lowered shares of LeMaitre Vascular (NASDAQ:LMAT – Free Report) from a buy rating to a hold rating in a research note released on Saturday. Several other research firms have also issued reports on LMAT. Barrington Research raised their price objective on LeMaitre Vascular from $69.00 to $79.00 and gave the company an outperform rating […]
LeMaitre Vascular (NASDAQ:LMAT) Downgraded by StockNews com dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) hit a new 52-week high during trading on Monday after StockNews.com upgraded the stock from a hold rating to a buy rating. The stock traded as high as $75.99 and last traded at $75.71, with a volume of 62552 shares changing hands. The stock had […]